Appointments: Lilly, Kiadis, Pliant, Alma, NeuroVia and Nektar Therapeutics

This week's roundup includes a handful of promotions by Eli Lilly, and various board and high-level appointments by companies including Kiadis Pharma, Aeterna Zentaris, Dermavant Sciences and Pliant Therapeutics.

Eli Lilly & Co. has promoted Josh Smiley to senior vice president and chief financial officer (CFO); he will also become a member of Lilly's executive committee. Derica Rice, Lilly's current CFO, will retire at the end of the year. Myles O'Neill has been promoted to senior vice president and president of manufacturing operations and will join Lilly's executive committee. Aarti Shah, senior vice president and chief information officer, has been appointed executive officer and will join Lilly's executive committee. These appointments will be effective January 1, 2018. Dan Skovronsky has been promoted to senior vice president for science and technology and president of Lilly Research Labs and will also become a member of Lilly's executive committee – effective June 1, 2018. Maria Crowe, Lilly's president of manufacturing operations, and Jan Lundberg, executive vice president for science and technology and president of Lilly Research Labs, will both be retiring from the company.

The International Society for Cellular Therapy (ISCT) has named Queenie Jang CEO. Jang has been an external consultant for ISCT...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Executives On The Move

More from Leadership